| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7b5d728d4890268356fcc07e6e53840c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1676
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-64 |
| filingDate |
2006-05-16^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aabba7c3bb729162d2eb7d4dea3d1a38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62458bb062c404c65f74410c23f157d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b54a8b44132fdc282b02f1df5c643346
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd86dbc316a5d92a353726a01c391b8f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8dc438d118fa78928900c713579075bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f21645af4d58cee74af78f9b18e9d0e |
| publicationDate |
2009-04-15^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MX-2007014363-A |
| titleOfInvention |
COMPOSITIONS OF CONTROLLED RELEASE AND IN THE FORM OF NANOPARTICLES THAT INCLUDE A CEPHALOSPORINE. |
| abstract |
The present invention is directed to compositions comprising an antibiotic in the form of nanoparticles having improved bioavailability. Preferably, the antibiotic comprises cephalosporin particles in the form of nanoparticles with an average particle size of less than about 2000 nm and are useful in the treatment of bacterial infections. The invention also concerns a controlled release composition comprising a cephalosporin or a cephalosporin in the form of nanoparticles that in operation releases the drug in a bimodal or impulse manner for the treatment of bacterial infections. Cephalosporin particles in the form of nanoparticles can be formulated as a controlled release drug delivery system whereby the particles are coated one or more times with one or more natural or synthetic hydrophobic and / or hydrophilic polymer coating materials. or dispersed throughout a natural or synthetic hydrophilic and / or hydrophilic polymer matrix. |
| priorityDate |
2005-05-16^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |